混合链位移电路控制的CRISPR-Cas13a激活,用于对非RNA分析物的单一探测
1Department of Laboratory Medicine and Institute of Molecular Medicine (IMM), Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.
Biosensors & bioelectronics
|August 14, 2025
概括
这项研究引入了一个新的CRISPR-Cas13a传感平台,用于在单个步骤中检测非核酸目标. 这一创新扩大了CRISPR诊断的实用性,超出了DNA和RNA检测的范围.
科学领域:
- 分子生物学分子生物学
- 生物技术是生物技术.
- 生物感应是一种生物感应.
背景情况:
- 克里斯普尔-卡斯系统为分子诊断提供高灵敏度和特异性.
- 目前的应用主要局限于核酸点.
- 需要使用CRISPR技术检测非核酸分析物.
研究的目的:
- 开发一种可通用的CRISPR-Cas13a传感平台,用于单一检测非核酸目标.
- 为了使更广泛的分析品能够进行混合和读取测试.
主要方法:
- 一个基于DNA:RNA链位移的混合开关被设计成条件激活CRISPR-Cas13a.
- 该开关利用Cas13a对单链RNA激活器的要求,确保目标触发激活.
- 功能性DNAs (DNAzyme, aptazyme,双重性aptamer) 与Cas13a开关集成,用于多种目标检测.
主要成果:
- 一套单CRISPR-Cas13a传感器被构建用于检测离子,ATP和血栓等目标.
- 传感器在复杂的生物样本中表现出增强的灵敏度,高选择性和强大的性能.
- 该平台表现出高度的模块化,通过修改功能性DNA序列,可以快速适应新的目标.
结论:
- 开发的CRISPR-Cas13a传感平台成功地将CRISPR系统的应用扩展到非核酸目标.
- 这种多功能策略为灵活,敏感和单一检测临床和环境相关分子提供了基础.
- 模块化设计促进了快速的传感器重新配置,加速了诊断工具的开发.
相关概念视频
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
CRISPR/Cas9 Genome Editing
220
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
220


